Abstract
Although the developers of the Positive and Negative Syndrome Scale (PANSS) grouped items into three subscales, factor analyses indicate that a five-factor model better characterizes PANSS data. However, lack of consensus on which model to use limits the comparability of PANSS variables across studies. We counted “votes” from published factor analyses to derive consensus models. One of these combined superior fit in our Caucasian sample (n=458, CFI = .970), and in distinct Japanese sample (n=164, CFI = .964), relative to the original three-subscale model, with a sorting of items into factors that was highly consistent across the studies reviewed.
Keywords: Schizophrenia, symptoms, cognition, PANSS
1. Introduction
The Positive and Negative Syndrome Scale (PANSS) is a 30-item rating scale designed by Kay et al. (1987) to assess dimensions of schizophrenia symptoms. Its items were originally grouped into scales for Positive Symptoms (7 items), Negative Symptoms (7 items), and General Psychopathology (16 items). Several factor-analytic studies have suggested that a five-factor model better captures PANSS structure in schizophrenia samples. In these studies, smaller groupings of items represent Positive and Negative symptoms, and three other factors consistently emerge, which we will refer to as Disorganized/Concrete, Excited, and Depressed. The PANSS factor-analytic literature also includes four, six (Van den Oord et al., 2006), and seven-factor (Emsley et al., 2003) models, but few. Versions of the five-factor model have been used in diverse schizophrenia research areas including treatment-response (von Knorring & Lindstrom, 1995), functioning (Llorca et al., 2011), and insight (Monteiro et al., 2008). It also provides good fit in other psychotic disorders (Serretti & Olgiati, 2004) and has revealed associations in instances when the original three subscales have not (e.g. theory of mind associations, Abdel-Hamid et al., 2009). Despite the general similarity of five–factor models, no single model has achieved broad consensus, and the three original subscales are still widely used. In addition, van der Gaag et al. (2006a) failed to find adequate fit in any of 25 published five-factor model variations applied to a distinct dataset. We use PANSS five-factor models reported in the literature to guide the construction of a new “consensus” model, extending previous work by Lehoux et al. (2009). We use a larger collection of published models and test and refine the consensus model with confirmatory factor analysis (CFA). We sought additional support for the model by assessing its fit in a second, demographically distinct schizophrenia sample.
2. Methods
2.1 Measure
The PANSS is a thirty-item measure of symptom severity (Kay et al., 1987). Trained interviewers administered the PANSS as part of a structured clinical interview and scored items on a scale from 1 (asymptomatic) to 7 (extremely symptomatic).
2.2 Literature Review
We searched for articles reporting novel five-factor models of the PANSS (see supplementary materials for methods). Across included studies, the five broad factors were congruent. To determine the literature “consensus” for assignment of individual items to the five factors, we simply counted how many times, across studies, each PANSS item was assigned to each factor.
2.3 Participants
We analyzed PANSS ratings for 458 unrelated individuals with DSM-IV diagnoses of schizophrenia or schizoaffective disorder. Data were collected during their participation in the Clinical Brain Disorders Branch/National Institute of Mental Health Genetic Study of Schizophrenia, described previously (Egan et al., 2001) (Table 1). Individuals with more than two PANSS items missing, IQ below 70, history of drug/alcohol abuse, head trauma, neurological disease, or age below 18 or above 55 were excluded. All participants gave written informed consent and completed a structured diagnostic interview and neuropsychological testing as part of a protocol approved by the NIH Institutional Review Board. Neuropsychological testers were blind to PANSS ratings.
Table 1.
Demographic information NIMH sample (n=458)
| Means | |
|---|---|
| Age | 34.8 ± 9.9 |
| % Caucasian | 81% |
| % Male | 75% |
| Yrs. Education | 14.1 ± 2.3 |
| Acute Age | 22.0 ± 5.6 |
| WAIS IQ | 92.2 ± 11.3 |
| “g” (z-scores) | −1.27 ± 0.72 |
2.4 Statistical Analysis
Model comparisons were performed using CFA in Mplus (Muthén & Muthén, 1998–2007; www.statmodel.com). We did not individually analyze each factor structure derived in the literature. Rather, as noted, we counted the “votes” of the different studies for particular PANSS item-factor assignments. We then compared a model based on the original PANSS subscales with a sequence of five-factor models that varied by consistency of specific item-factor assignments in the literature review. The models tested ranged from a very inclusive model, reflecting any item-factor assignment appearing in at least 10 of the 29 factor analyses reviewed, to a more restrictive model including item-factor assignments that were consistent across at least 26 of the 29 reports. Items were missing in 0–2% of cases. Stereotyped thinking (N7) was missing most often. It was, however, included in only 19 of 29 published models and only in the same factor 12 times. Tension (G4) met inclusion for two factors (Excited and Depressed) in one of our tested models. We assigned it to Depressed because it was assigned there most frequently.
We used a polychoric correlation matrix and full information estimation with a weighted least squares mean and variance adjusted method of CFA, which is appropriate for ordinal data (Flora & Curran, 2004). Models assessed by CFA are considered to have adequate fit when the Comparative Fit Index (CFI) and Non-Normed Fit Index (NNFI) are greater than 0.90 and the Root Mean Square Errors of Approximation (RMSEA) is less than 0.08 (Kline, 2010). CFI and NNFI are both included because, while CFI improves with greater model complexity, NNFI incorporates a penalty for each additional parameter. The AIC is included because it allows for comparison between models, with lower values indicating better relative fit.
Individual scores for each factor were calculated by dividing the sum of included item scores by the number of items in the factor. We also calculated Spearman correlations between scores on the new Positive and Negative factors with the broader Positive and Negative subscales.
To explore associations between symptoms and cognition, we calculated Spearman correlations between PANSS and cognitive variables. Cognitive performance was indexed using a four-subtest estimate of WAIS Full Scale IQ, as well as a composite score representing general cognitive ability (“g,” see supplementary materials and Dickinson et al., 2011).
We explored whether our literature-derived factors differed with sex, as our main sample is 75% male.
2.5 Replication in a Novel Sample
We compared the original subscales with our preferred five-factor model in a distinct sample of 164 Japanese patients with schizophrenia (Ohi et al., 2011) (Table 2).
Table 2.
Demographic information Japanese sample (n=164)
| Means | |
|---|---|
| Age | 37.4 ± 11.5 |
| % Male | 55% |
| Yrs. Education | 14.5 ± 2.2 |
| Acute Age | 23.9 ± 7.7 |
3. Results
3.1 Literature
The literature search yielded 29 five-factor models derived from apparently independent samples (Table 3). Of the 30 PANSS items, seven entered fewer than 20 models and only two had consistent assignment across all 29 models (Table 4).
Table 3.
Published models included in analysis
| Paper | Method: Rotation |
|---|---|
| Bell et al., 1994 (Bronx) | PCA: Equamax |
| Bell et al., 1994 (WHVA) | PCA: Equamax |
| Bunk et al., 1999 | PCA: Varimax |
| Citrome et al., 2011 | EFA: Varimax |
| Dollfus et al., 1995 (discharge) | PCA: Varimax |
| Drake et al., 2003 (final model) | PCA: Equamax |
| Dudek, 2005 (revised) | PCA: Varimax |
| Emsley et al., 2003 | PCA: Equamax |
| Fredrikson et al., 1997 | EFA: maximum likelihood |
| Fresán et al., 2005 | PCA: Equamax |
| Higashima et al., 1998 | PCA: Equamax |
| Kay & Sevy, 1990 | PCA: Equamax |
| Lançon et al., 2000 (chronic) | PCA: Varimax |
| Lançon et al., 2000 (relapse) | PCA: Varimax |
| Lee et al., 2003 | PCA: Equamax |
| Lépine, 1991 | PCA |
| Levine & Rabinowitz, 2007 | PCA: Promax |
| Lindenmayer et al. 1995a | PCA: Equamax |
| Lindenmayer et al. 1995b (wash-out) | PCA: Equamax |
| Lindstrom & von Knorring, 1993 | PCA: Varimax |
| Lykouras et al. 2000 | PCA: Varmiax; CFA |
| Marder et al., 1997 (placebo) | PCA: Equamax |
| Marder et al., 1997 | PCA: Equamax |
| Marder et al., 1997 (risperidone) | PCA: Equamax |
| Mass et al., 2000 (haloperidol) | PCA: Equamax |
| van den Oord et al., 2006 | PCA: Promax |
| van der Gaag et al., 2006b | 10-Fold Cross Validation |
| White et al., 1997 | CFA; EFA: Varimax |
| Wolthaus et al., 2000 | PCA: Varimax, Equamax (and an unspecified Oblique method) |
Table 4.
Literature summary showing how many times out of 29 published models each PANSS item loaded on each factor. Items included in the final preferred model are highlighted.
| Symptom | Item | POSITIVE | NEGATIVE | DISORGANIZE D/CONCRETE | EXCITED | DEPRESSED |
|---|---|---|---|---|---|---|
| Delusions | P1 | 29 | ||||
| Conceptual | P2 | 1 | 27 | |||
| Hallucinations Disorganization | P3 | 26 | 1 | 1 | 1 | |
| Excitement | P4 | 1 | 27 | |||
| Grandiosity | P5 | 24 | 3 | |||
| Suspiciousness/Persecut | P6 | 22 | 1 | 2 | ||
| Hostility ion | P7 | 29 | ||||
| Blunted Affect | N1 | 28 | ||||
| Emotional Withdrawal | N2 | 27 | ||||
| Poor Rapport | N3 | 28 | 2 | 1 | ||
| Passive/Apathetic Social | N4 | 27 | ||||
| Difficulty in Abstraction Withdrawal | N5 | 1 | 27 | |||
| Lack of Spontaneity | N6 | 28 | 1 | |||
| Stereotyped Thinking | N7 | 5 | 12 | 2 | ||
| Somatic Concern | G1 | 8 | 1 | 15 | ||
| Anxiety | G2 | 1 | 27 | |||
| Guilt Feelings | G3 | 28 | ||||
| Tension | G4 | 1 | 11 | 16 | ||
| Mannerisms and | G5 | 3 | 18 | 1 | ||
| Depression Posturing | G6 | 28 | ||||
| Motor Retardation | G7 | 24 | 1 | |||
| Uncooperativeness | G8 | 3 | 24 | |||
| Unusual Thought | G9 | 26 | 3 | |||
| Disorientation Content | G10 | 1 | 21 | 2 | 1 | |
| Poor Attention | G11 | 2 | 25 | 1 | ||
| Lack of Judgment and | G12 | 16 | 3 | 3 | ||
| Disturbance of Volition Insight | G13 | 8 | 10 | |||
| Poor Impulse Control | G14 | 1 | 27 | |||
| Preoccupation | G15 | 3 | 2 | 12 | 6 | |
| Active Social Avoidance | G16 | 1 | 20 | 3 | 4 |
3.2 Model
CFA demonstrated that the three-subscale model fit the data poorly (Table 5). Among the five-factor models, the most selective – including only 16 items – fit the data marginally better than more inclusive models. While fit statistics guided our choice, so did consistency of item-factor assignment in the literature. As there was a small natural break between items included in 22/29 models and in 24/29, we selected the 24/29 model. This model comprises 20 items categorized into Positive, Negative, Disorganized/Concrete, Excited, and Depressed factors. Factor loadings for individual items are strong, and bivariate correlations between factors are small (Tables 6 & 7). Four factors (all but Depressed) draw items from more than one original subscale.
Table 5.
Confirmatory Factor Analysis Results
| Model | df | Chi Square | AIC | CFI | RMSEA | NNFI | # items |
|---|---|---|---|---|---|---|---|
| Traditional PANSS 3-subfactor Model | 89 | 1416.03 | 1238.03 | 0.703 | 0.185 | 0.776 | 30 |
| Items included ≥10/29 models | 96 | 534.69 | 342.69 | 0.902 | 0.102 | 0.931 | 30 |
| Items included ≥15/29 models | 86 | 503.28 | 331.28 | 0.908 | 0.105 | 0.934 | 27 |
| Items included ≥20/29 models | 69 | 390.84 | 252.84 | 0.929 | 0.103 | 0.948 | 23 |
| Items included ≥21/29 models | 66 | 326.97 | 194.97 | 0.943 | 0.095 | 0.957 | 22 |
| Items included ≥23/29 models | 62 | 299.37 | 175.37 | 0.950 | 0.093 | 0.962 | 21 |
| Items included ≥24/29 models | 58 | 290.43 | 174.43 | 0.950 | 0.095 | 0.961 | 20 |
| Items included ≥25/29 models | 45 | 175.79 | 85.79 | 0.972 | 0.081 | 0.978 | 17 |
| Items included ≥26/29 models | 40 | 126.02 | 46.02 | 0.981 | 0.070 | 0.985 | 16 |
| Independent sample (≥24/29 model) | 43 | 153.81 | 67.81 | 0.941 | 0.127 | 0.975 | 20 |
| Independent sample 3-subfactor Model | 50 | 984.27 | 884.27 | 0.517 | 0.344 | 0.787 | 30 |
Table 6.
Final Literature-Derived 5-Factor Model of the PANSS Standardized Estimates of Regression Weights
| Positive Factor | Negative Factor | Disorganized/Concrete Factor | Excited Factor | Depressed Factor | R2 | |
|---|---|---|---|---|---|---|
| P1 | 0.84 | 0.71 | ||||
| P3 | 0.70 | 0.49 | ||||
| P5 | 0.74 | 0.55 | ||||
| G9 | 0.97 | 0.94 | ||||
| N1 | 0.84 | 0.71 | ||||
| N2 | 0.91 | 0.83 | ||||
| N3 | 0.85 | 0.72 | ||||
| N4 | 0.93 | 0.86 | ||||
| N6 | 0.84 | 0.71 | ||||
| G7 | 0.86 | 0.74 | ||||
| P2 | 0.85 | 0.72 | ||||
| N5 | 0.41 | 0.17 | ||||
| G11 | 0.80 | 0.64 | ||||
| P4 | 0.88 | 0.77 | ||||
| P7 | 0.89 | 0.79 | ||||
| G8 | 0.84 | 0.71 | ||||
| G14 | 0.69 | 0.48 | ||||
| G2 | 0.68 | 0.46 | ||||
| G3 | 0.73 | 0.53 | ||||
| G6 | 0.80 | 0.64 |
Table 7.
Final Literature-Derived 5-Factor Model of the PANSS factor correlations between factors
| Positive Factor | Negative Factor | Disorganized/Concrete Factor | Excited Factor | Depressed Factor | |
|---|---|---|---|---|---|
| Positive Factor | 1 | ||||
| Negative Factor | 0.191 | 1 | |||
| Disorg/Conc Factor | 0.424 | 0.479 | 1 | ||
| Excited Factor | 0.340 | 0.213 | 0.218 | 1 | |
| Depressed Factor | 0.280 | 0.066 | 0.100 | 0.238 | 1 |
We found strong factor-to-subscale correlations for Positive (r=0.90) and Negative (r=0.97) scales.
CFA of our preferred model yielded adequate fit in the independent Japanese dataset (Table 5). Again, the three-subscales demonstrated poor fit.
3.3 Cognition and Demographics
All three original subscales correlated modestly but significantly with IQ and “g.” In our model, the Disorganized/Concrete factor accounted for the largest share of the PANSS association with cognition (Table 8).
Table 8.
Spearman correlations between original PANSS dimensions versus new PANSS factors and WAIS IQ and g
| Positive Dimension | Negative Dimension | General Psychopathology | Positive Factor | Negative Factor | Disorganiz d/Concrete Factor | Excited Factor | Depressed Factor | |
|---|---|---|---|---|---|---|---|---|
| WAIS IQ | −0.187* | −0.293** | −0.160* | −0.102* | −0.236** | −0.347*** | −0.161* | 0.032 |
| g | −0.208* | −0.263** | −0.191* | −0.105* | −0.196* | −0.403*** | −0.167* | −0.001 |
p < .05
p < 5 E-5
p< 5 E-10
Consistent with previous research, males had higher Negative factor scores (F [df1,447]=1.443, p=0.027). Other factors did not differ significantly with sex.
4. Discussion
Current results contribute to the literature suggesting that five-factor models better represent the dimensional structure of PANSS data than the original three subscales. High correlations between original subscales and proposed factors for Negative and Positive symptoms suggest that the factors capture the essence of these critical symptom dimensions and, as in prior work, additional factors for Disorganized/Concrete, Excited and Depressed provide an empirically-based differentiation of other symptom dimensions. These results also offer a “consensus” model that might enhance comparability across studies. Across tested models, increasing selectivity yielded improved quantitative model fit. Psychometric and clinical considerations, however, favor retention of as many items as show reasonable consistency in their factor-assignment across the literature models, rather than overvaluation of small differences in fit indices. Some arbitrariness is unavoidable, but our proposed model appears to offer the best overall balance between good statistical fit and consistent factor-assignment. In sum, the proposed five-factor model offers psychometrically-coherent and relatively-discrete signals in Caucasian and Japanese samples.
Limitations of our work include, first, relatively small factors; two factors comprise only three items. Another issue is the exclusion from our preferred model of Suspiciousness/Persecution (P6) – a hallmark schizophrenia symptom. Including P6 consistently led to worse fit. This may reflect a clinical reality: paranoia can be present in various symptom configurations, and sometimes appears with few other major symptoms (American Psychiatric Association, 2000). P6 may simply represent a distinct symptom domain, only sparsely assessed by the PANSS.
The PANSS has recognized drawbacks, including reliance on limited behavioral observation for some items and patient report for others (Blanchard et al., 2011) and a vague ordinal rating metric (Cohen et al., 2008). In response, researchers are developing new symptom assessment methods. Although new measures will be valuable, many studies continue to collect PANSS data. It remains to be seen whether the five-factor model will supplant the traditional PANSS subscales in clinical practice. Much experience is required to determine how the factors compare with the subscales in relation to matters of clinical characterization and improvement with treatment, and whether the item groupings proposed here suit clinicians’ preferences.
Although perhaps schizophrenia symptom dimensions could be adequately assessed with a briefer instrument, we do not advocate cutting items or other changes in PANSS administration. Given the strong likelihood of continued use of five-factor PANSS models in research, current analyses offer a possible compromise among slightly varying five-factor models that balances quantitative, psychometric and clinical considerations, and that might enhance comparisons across studies.
Supplementary Material
Acknowledgments
We thank Drs. Ann Reifman and Lou Bigelow, who administered the PANSS. We also thank Ms. Sally Cheung, who managed the database.
Role of funding source
Funding for this study was provided by the Intramural Research Program of the National Institute of Mental Health; the NIMH IRP had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
Footnotes
Contributors
R.S.W., R.F. and D.D. conducted statistical analyses on previously-collected data, RH and DRW designed and supervised the original collection of the data, and all authors (R.S.W., R.F., R.H., D.R.W. and D.D.) were involved in the writing of the manuscript.
Conflicts of interest
All authors declare that they have no conflicts of interest.
Supplementary materials related to this article can be found online at:
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- Abdel-Hamid M, Lehmkämper C, Sonntag C, Juckel G, Daum I, Brüne M. Theory of mind in schizophrenia: The role of clinical symptomatology and neurocognition in understanding other people’s thoughts and intentions. Psychiatr Res. 2009;165(1–2):19–26. doi: 10.1016/j.psychres.2007.10.021. [DOI] [PubMed] [Google Scholar]
- American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders. 4. American Psychiatric Association; Washington, DC: 2000. Text Revision. [Google Scholar]
- Bell MD, Lysaker PH, Beam-Goulet JL, Milstein RM, Lindenmayer JP. Five- component model of schizophrenia: assessing the factorial invariance of the Positive and Negative Syndrome Scale. Psychiatry Res. 1994;52(3):295–303. doi: 10.1016/0165-1781(94)90075-2. [DOI] [PubMed] [Google Scholar]
- Blanchard JJ, Kring AM, Horan WP, Gur R. Toward the next generation of negative symptom assessments: The collaboration to advance negative symptom assessment in schizophrenia. Schizophr Bull. 2011;37(2):291–299. doi: 10.1093/schbul/sbq104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bunk D, Eggers C, Klapaln M. Symptom dimensions in the course of child-onset schizophrenia. Eur Child Adolesc Psychiatry. 1999;8(Supplement 1):I/29–I/35. doi: 10.1007/pl00010688. [DOI] [PubMed] [Google Scholar]
- Citrome L, Meng X, Hochfeld M. Efficacy of iloperidone in schizophrenia: A PANSS five-factor analysis. Schizophr Res. 2011;131(1–3):75–81. doi: 10.1016/j.schres.2011.05.018. [DOI] [PubMed] [Google Scholar]
- Cohen AS, Alpert M, Nienow TM, Dinzeo TJ, Docherty NM. Computerized measurement of negative symptoms in schizophrenia. J Psychiatr Res. 2008;42(10):827–836. doi: 10.1016/j.jpsychires.2007.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dickinson D, Goldberg TE, Gold JM, Elvevåg B, Weinberger DR. Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. Schizophr Bull. 2011;37(6):1157–1167. doi: 10.1093/schbul/sbq018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dollfus S, Petit M. Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase. Eur Psychiatr. 1995;10(2):97–106. doi: 10.1016/0924-9338(96)80320-8. [DOI] [PubMed] [Google Scholar]
- Drake RJ, Dunn G, Tarrier N, Haddock G, Haley C, Lewis S. The evolution of symptoms in the early course of non-affective psychosis. Schizophr Res. 2003;63(1–2):171–179. doi: 10.1016/s0920-9964(02)00334-1. [DOI] [PubMed] [Google Scholar]
- Dudek PT. Unpublished manuscript. Philadelphia: 2005. An Examination of the Factor Structure of the SCI-PANSS. [Google Scholar]
- Egan MF, Goldberg TE, Gscheidle T, Weirich M, Rawlings R, Hyde TM, Bigelow L, Weinberger DR. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry. 2001;50(2):98–107. doi: 10.1016/s0006-3223(01)01133-7. [DOI] [PubMed] [Google Scholar]
- Emsley R, Rabinowitz J, Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res. 2003;61(1):47–57. doi: 10.1016/s0920-9964(02)00302-x. [DOI] [PubMed] [Google Scholar]
- Flora DF, Curran PJ. An Empirical Evaluation of Alternative Methods of Estimation for Confirmatory Factor Analysis with Ordinal Data. Psychol Methods. 2004;9(4):466–491. doi: 10.1037/1082-989X.9.4.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fredrikson D, Steiger J, MacEwan G, Altman S, Kopala L, Flyn S, Liddle P, Honer W. PANSS symptom factors in schizophrenia. Schizophr Res. 1997;24(1–2):15–16. [Google Scholar]
- Fresán A, De la Fuente-Sandoval C, Loyzaga C, García-Anaya M, Meyenberg N, Nicolini H, Apiquian R. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenia patients. Schizophr Res. 2005;72(2–3):123–129. doi: 10.1016/j.schres.2004.03.021. [DOI] [PubMed] [Google Scholar]
- Higashima M, Urata K, Kawasaki Y, Maeda Y, Sakai N, Mizukoshi C, Nagasawa T, Kamiya T, Yamaguchi N, Koshino Y. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia. Biol Psychiatry. 1998;44(2):115–120. doi: 10.1016/s0006-3223(97)00359-4. [DOI] [PubMed] [Google Scholar]
- Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull. 1987;13(2):261–276. doi: 10.1093/schbul/13.2.261. [DOI] [PubMed] [Google Scholar]
- Kay SR, Sevy S. Pyramidical model of schizophrenia. Schizophr Bull. 1990;16(3):537–545. doi: 10.1093/schbul/16.3.537. [DOI] [PubMed] [Google Scholar]
- Kline RB. Principles and Practice of Structural Equation Modeling. New York: Guilford; 2010. [Google Scholar]
- Lançon C, Auquier P, Nayt G, Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS) Schizophr Res. 2000;42(3):231–239. doi: 10.1016/s0920-9964(99)00129-2. [DOI] [PubMed] [Google Scholar]
- Lee K-H, Harris AW, Loughland CM, Williams LM. The Five Symptom Dimensions and Depression in Schizophrenia. Psychopathology. 2003;36(5):226–233. doi: 10.1159/000073447. [DOI] [PubMed] [Google Scholar]
- Lehoux C, Gobeil MH, Lefebvre AA, Maziade M, Roy MA. The Five-Factor Structure of the PANSS: A Critical Review of its Consistency Across Studies. Clin Schizophr Relat Psychoses. 3(2):103–110. [Google Scholar]
- Lépine JP. Dimensions positives et négatives dans les schizophrénies. Les Cahiers de Prisme. 1991;1:23–29. [Google Scholar]
- Levine SZ, Rabinowitz J. Revisiting the 5 Dimensions of the Positive and Negative Syndrome Scale. J Clin Psychopharmacol. 2007;27(5):431–436. doi: 10.1097/jcp/.0b013e31814cfabd. [DOI] [PubMed] [Google Scholar]
- Lindenmayer J-P, Bernstein-Hyman R, Grochowski S, Bark N. Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology. 1995a;28(1):22–31. doi: 10.1159/000284896. [DOI] [PubMed] [Google Scholar]
- Lindenmayer J-P, Grochowski S, Hyman RB. Five factor model of schizophrenia: replication across samples. Schizophr Res. 1995b;14(3):229–234. doi: 10.1016/0920-9964(94)00041-6. [DOI] [PubMed] [Google Scholar]
- Lindstrom E, von Knorring L. Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale for schizophrenia. Nord J of Psychiatry. 1993;47(4):257–263. [Google Scholar]
- Llorca PM, Blanc O, Samalin L, Bosia M, Cavallaro R on behalf of the EGOFORS initiative. Eur Psychiatry. Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling. in press. Available online 30 June 2011. [DOI] [PubMed] [Google Scholar]
- Lykouras L, Oulis P, Psarros K, Daskalopoulou E, Botsis A, Christodoulou VN, Stefanis C. Five-factor model of schizophrenic psychopathology: how valid is it? Eur. Arch Psychiatry Clin Neurosci. 2000;250(2):93–100. doi: 10.1007/s004060070041. [DOI] [PubMed] [Google Scholar]
- Marder SR, Davis JM, Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. J Clin Psychiatry. 1997;58(12):538–546. doi: 10.4088/jcp.v58n1205. [DOI] [PubMed] [Google Scholar]
- Mass R, Schoemig T, Hitschfeld K, Wall E, Haasen C. Psychopathological Syndromes of Schizophrenia: Evaluation of the Dimensional Structure of the Positive and Negative Syndrome Scale. Schizophr Bull. 2000;26(1):167–177. doi: 10.1093/oxfordjournals.schbul.a033437. [DOI] [PubMed] [Google Scholar]
- Monteiro LC, Silva VA, Louza MR. Insight, cognitive dysfunction and symptomatology in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2008;258(7):402–5. doi: 10.1007/s00406-008-0809-8. [DOI] [PubMed] [Google Scholar]
- Muthén LK, Muthén B. Mplus user’s guide, version 4. Muthén & Muthén; Los Angeles: 1998–2007. [Google Scholar]
- Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Yamamori H, Umeda-Yano S, Kamino K, Ikezawa K, Azechi M, Iwase M, Kazui H, Kasai K, Takeda M. The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(5):1309–1315. doi: 10.1016/j.pnpbp.2011.04.008. [DOI] [PubMed] [Google Scholar]
- Serretti A, Olgiati P. Dimensions of major psychoses: a confirmatory factor analysis of six competing models. Psychiatry Res. 2004;127(1–2):101–109. doi: 10.1016/j.psychres.2003.07.005. [DOI] [PubMed] [Google Scholar]
- Van den Oord EJCG, Rujescu D, Robles JR, Giegling I, Birrell C, Bukszár J, Murrelle L, Möller HJ, Middleton L, Muglia P. Factor structure and external validity of the PANSS revisited. Schizophr Res. 2006;82:213–223. doi: 10.1016/j.schres.2005.09.002. [DOI] [PubMed] [Google Scholar]
- van der Gaag M, Cuijpers A, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, van Harten PN, Valmaggia L, de Hert M, Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale I: Confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr Res. 2006a;85(1–3):273–279. doi: 10.1016/j.schres.2006.04.001. [DOI] [PubMed] [Google Scholar]
- van der Gaag M, Hoffman T, Remijsen M, Jihman R, de Haan L, van Meijel B, van Harten PN, Valmaggia L, de Hert M, Cuijpers A, Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model. Schizophr Res. 2006b;85(1–3):280–287. doi: 10.1016/j.schres.2006.03.021. [DOI] [PubMed] [Google Scholar]
- von Knorring L, Lindstrom E. Principal components and further possibilities with the PANSS. Acta Psychiatr Scand. 1995;91(suppl 388):5–10. doi: 10.1111/j.1600-0447.1995.tb05937.x. [DOI] [PubMed] [Google Scholar]
- White I, Harvey PD, Opler L, Lindenmayer JP Group tPS. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopharmacology. 1997;30(5):263–274. doi: 10.1159/000285058. [DOI] [PubMed] [Google Scholar]
- Wolthaus JE, Dingemans PM, Schene AH, Linszen DH, Knegtering H, Holthausen EA, Cahn W, Haijman R. Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology (Berl) 2000;150(4):399–403. doi: 10.1007/s002130000459. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
